Fabtech Technologies Limited — PPTs, 28-07-2026: Investor Presentation

Here's a summary of the investor presentation, keeping your preferences in mind:

**Business Performance:** Fabtech Technologies saw robust year-on-year growth with revenue up 10.3%. The company swung from a loss to a profit of ₹4.21 Cr. This improvement was driven by a significant expansion in contribution margin by 910 basis points, aided by better project selection, procurement, and execution. Employee costs saw a reduction of 2.8%.

**Growth Drivers or Strategy:** Fabtech is focusing on global expansion and operational excellence. Key strategic areas include leveraging the accelerating capex in biologics and specialty pharma, and capitalizing on healthcare infrastructure investments in the GCC and Africa. The "China+1" strategy is also driving demand for manufacturing diversity.

**Recent Developments:** The company's core strength lies in its integrated turnkey solutions for the life sciences and healthcare sectors, with in-house manufacturing of Process, Air & Water systems. They are expanding their presence in markets like Saudi Arabia, which saw revenue grow by 130%.

**Key Financial Metrics:**

* Revenue: ₹74.98 Cr (up 10.3% YoY)

* Profit After Tax (PAT): ₹4.21 Cr (from a loss of ₹6.13 Cr)

* Contribution Margin: 46.7% (up 910 bps)

**Management Commentary / Outlook:** For FY27, Fabtech anticipates 20-25% YoY organic growth driven by a strong order pipeline and good business visibility. The second half of the year is expected to be stronger, with significant opportunities in Africa. The company aims to build a resilient and admired institution in life sciences engineering.